R.Y. Lei

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

Jean-Pascal Machiels, R. Todd Reilly, Leisha A. Emens et al. · PubMed · 2001 · 459 citations · Full text

Medicine, Immunology, Oncology +15

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.

R. Todd Reilly, Jean-Pascal Machiels, Leisha A. Emens et al. · PubMed · 2001 · 152 citations · Full text

Medicine, Immunology, Oncology +17

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

David L. Greenspan, Denise C. Connolly, Rong Wu et al. · PubMed · 1997 · 134 citations

Medicine, Genetics, Molecular Genetics +11

Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT)

R.Y. Lei, Charles E. Leonard, Kathryn Howell et al. · Breast Cancer Research and Treatment · 2013 · 50 citations · Full text

Medicine, Oncology, Radiation Oncology +16

The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12‐gene DCIS score™ result

Michael Alvarado, Dennis L. Carter, J. Michael Guenther et al. · Journal of Surgical Oncology · 2015 · 46 citations

Medicine, Oncology, Radiation Oncology +17